Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Filtravate logo — Filter the Future™

Filtravate

Filter the Future™

Founded 2020 United States Las Cruces, United States 2 employees Seed Total: $700.00K Biotechnology, Pharmaceutical

General Information

Company Name Filtravate
Founded Year 2020
Location United States Las Cruces, United States
Employees 2
Industries Biotechnology, Pharmaceutical
Funding Stage Seed
Business Model B2B, D2C
Revenue Model Product Sales, Licensing, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with Filtravate. To contact Filtravate, visit filtravate.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Filtravate compare?

A PDF of Filtravate and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Filtravate soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Filtravate

Filtravate, founded in 2020, is carving a niche in the burgeoning biotechnology and pharmaceutical sectors with their advanced bio-filtration membranes, under the compelling slogan, "Filter the Future™." Rooted in technology licensed from New Mexico State University, the company targets the expansive and underexplored multi-billion dollar biotechnology membrane market.

The United States-based company focuses on pioneering next-generation membranes designed to facilitate continuous bioprocessing, addressing critical needs in biomanufacturing and pharmaceuticals. This innovation positions Filtravate as a potential game-changer in enhancing efficiency and effectiveness across industry processes.

Most notably, Filtravate secured a $400.00K grant investment on 01 January 2024 from prominent investors like Los Alamos National Laboratory and the US Department of Energy, underlining substantial confidence in its technological promise and market potential.

Business keywords: bio-filtration membranes, biotechnology membrane market, continuous bioprocessing, biomanufacturing, pharmaceutical industries, ultrafiltration membranes, nanotechnology, advanced materials, anti-fouling technology, membrane technology, licensed technology, patent-pending innovations, functionalized surfaces, controlled pore size, bioprocessing solutions

Services & Products

Development of ultrafiltration membranes
Commercialization of membrane technology

Target Customers

Bioprocessing companies Biopharmaceutical industries

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $400.00K 2
Los Alamos National Laboratory, US Department of Energy
01 Jan 2024
Seed $300.00K -
01 Feb 2022
Seed Undisclosed -
01 Feb 2020

Filtravate Alternatives & Competitors

View All Alternatives
Filtravate vs
Alioth Biotech
Alioth Biotech China

Your Reliable Partner in Pharma Filtration Processing

Series A
22 employees
Biopharma, Biotechnology
Filtravate vs
Zai Lab
Zai Lab China

Delivering innovative, transformational outcomes to patients around the world

IPO
529 employees
Biotechnology, Health Care
Filtravate vs
Cybrexa Therapeutics
Cybrexa Therapeutics United States

Changing the paradigm for cancer treatment through the development of antigen-independent peptide dr...

Series B
11 employees
Biotechnology, Health and Wellness
View all alternatives

FAQ About Filtravate

Filter the Future™
Filtravate was founded in 2020.
Filtravate is headquartered in Las Cruces, United States.
Filtravate operates in Biotechnology and Pharmaceutical. Its work centres on bio-filtration membranes, biotechnology membrane market, continuous bioprocessing and biomanufacturing. Its customers include Bioprocessing companies and Biopharmaceutical industries.
Filtravate has a B2B and D2C business model. Its revenue comes from Product Sales, Licensing and Service Fee.
Filtravate has approximately 2 employees.
Filtravate has completed 3 funding rounds, raising a total of $700.00K. The latest funding stage is Seed.
Filtravate offers: Development of ultrafiltration membranes, Commercialization of membrane technology.
Top alternatives and competitors to Filtravate include Alioth Biotech, Zai Lab, Cybrexa Therapeutics, ArriVent Biopharma, HDT Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Filtravate and Alioth Biotech are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Filtravate, https://bouncewatch.com/company/filtravate, updated 11 March 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout